Volume : 13, Issue : 11, November – 2026
Title:
IN VITRO AND IN VIVO EVALUATION OF ANTI-ASTHMATIC ACTIVITY OF EUGENIA JAMBOLANA BARK
Authors :
Chichula Gouthami*, Dr. Neelam I, Dr. Nagaraj.M Kulkarni, G Vijaya Kumar
Abstract :
Asthma is a chronic respiratory disorder associated with airway hyperresponsiveness, bronchoconstriction and inflammatory changes in the airways. The present study was undertaken to evaluate the in vitro and in vivo anti-asthmatic activity of Eugenia jambolana bark extracts. The bark was extracted using aqueous and alcoholic solvents to obtain aqueous extract of Eugenia jambolana (AQEEJ) and methanolic extract of Eugenia jambolana (MEEJ). The percentage yields of the aqueous and alcoholic extracts were reported as 20.48% w/w and 11.45% w/w, respectively. Preliminary phytochemical screening revealed the presence of alkaloids, flavonoids, saponins, tannins, steroids/terpenoids, carbohydrates, resins and other phytoconstituents.
In the guinea pig ileum preparation, both extracts inhibited acetylcholine-induced contraction, with AQEEJ producing comparatively greater inhibition than MEEJ.
The acute toxicity observations reported in the study showed no significant behavioural or morphological toxic manifestations at the investigated doses. The observed inhibitory effects against histamine- and acetylcholine-induced smooth-muscle responses indicate that Eugenia jambolana bark extracts possess promising preliminary anti-asthmatic activity. The activity may be associated with the bioactive phytoconstituents present in the extracts. Further well-controlled in vivo studies and mechanistic investigations are required to establish the efficacy, safety and therapeutic potential of Eugenia jambolana bark extracts in asthma.
Keywords: Eugenia jambolana; Bark extract; Anti-asthmatic activity; Histamine; Acetylcholine; Guinea pig ileum; Bronchoconstriction; Phytochemical screening.
Cite This Article:
Please cite this article in press Chicula Gouthami et al., In Vitro And In Vivo Evaluation Of Anti-Asthmatic Activity Of Eugenia Jambolana Bark.,. Indo Am. J. P. Sci, 2026; 13(11).
REFERENCES:
1. Prasad R, Lawnia RD, Gupta MR. (2009). Role of herbs in the management of asthma. Pharmacog Rev, 3(6), 247-257.
2. Aggarwal AN, Chaudhry K, Chhabra SK, D’Souza GA, Gupta D, Jindal SK, Katiyar SK, Kumar R, Shah B, Vijayan VK. (2009). Prevalence and Risk Factors for Bronchial Asthma in Indian Adults: A Multicentre Study. Indian J Chest Dis Allied Sci, 48, 13-22.
3. Tattersfield AE, Knox AJ, Britton JR, Hall IP. (2002). Asthma. Lancet, 360,1313-1322.
4. Stevens DA, Schwartz HJ, Lee JY. (2000). A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med, 342, 756- 762.
5. Conron M, Beynon HLC.(2000). Churg-Strauss syndrome. Thorax, 55, 870- 877.
6. Szczeklik A, Nizankowska E, Duplaga M. (2000). On behalf of the AIANE Investigators. Natural history of aspirin-induced asthma. Eur Respir J,16, 432.
7. Saunders. (2005). Asthma. In: Homer A, Boushey JrMD, David B, Corry MD, John V, Fahy MD, Esteban G, Burchard MD, Prescott G, Woodruff MD, et al. ed. Mason: Murray & Nadel’s Textbook of Respiratory Medicine, 4th ed., Elsevier.
8. Yawn BP. (2008). Factors accounting for asthma variability, achieving optimal symptom control for individual patients. Prim Care Resp J, 17(3), 138–147.
9. Martinez FD. (2007). Genes, environments, development and asthma: A reappraisal. Eur Resp J, 29(1), 179–184.
10. Tattersfield AE, Knox AJ, Britton JR, Hall IP. (2002). Asthma. Lancet, 360,1313-1322.